Andrzej Górski

Q: What Schools Are Affiliated With Andrzej Górski

Andrzej Górski is affiliated with the following schools: Medical University of Warsaw, Jagiellonian University

Andrzej Górski's AcademicInfluence.com Rankings

Andrzej Górski

Biology

#13071

World Rank

#16596

Historical Rank

Immunology

#887

World Rank

#910

Historical Rank

biology Degrees

Download Badge

Biology

Andrzej Górski's Degrees

PhD Immunology Jagiellonian University
Doctorate Medicine Jagiellonian University

Why Is Andrzej Górski Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Andrzej Górski's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The influence of external factors on bacteriophages—review (2011) (431)
Bacteriophage Endolysins as a Novel Class of Antibacterial Agents (2006) (318)
Clinical aspects of phage therapy. (2012) (267)
Transplantation of Autologous Olfactory Ensheathing Cells in Complete Human Spinal Cord Injury (2013) (226)
Bacteriophage penetration in vertebrates (2005) (222)
The Phage Therapy Paradigm: Prêt-à-Porter or Sur-mesure? (2011) (221)
Phage as a modulator of immune responses: practical implications for phage therapy. (2012) (192)
Bacteriophage therapy of bacterial infections: an update of our institute's experience. (2000) (190)
Mammalian Host-Versus-Phage immune response determines phage fate in vivo (2015) (174)
Bacteriophage translocation. (2006) (166)
Quality and Safety Requirements for Sustainable Phage Therapy Products (2015) (166)
Seasonal Patterns of Stress, Immune Function and Disease (2002) (155)
The potential role of endogenous bacteriophages in controlling invading pathogens (2005) (141)
Bacteriophage therapy for the treatment of infections. (2009) (130)
Bacteriophage Procurement for Therapeutic Purposes (2016) (125)
Phage Therapy: Combating Infections with Potential for Evolving from Merely a Treatment for Complications to Targeting Diseases (2016) (118)
Phage neutralization by sera of patients receiving phage therapy. (2014) (113)
Immunogenicity Studies of Proteins Forming the T4 Phage Head Surface (2014) (110)
Phages and immunomodulation. (2017) (105)
Preparation of endotoxin-free bacteriophages. (2004) (103)
Bacteriophages as an efficient therapy for antibiotic-resistant septicemia in man. (2003) (101)
Expert Opinion on Three Phage Therapy Related Topics: Bacterial Phage Resistance, Phage Training and Prophages in Bacterial Production Strains (2018) (98)
Characterising the biology of novel lytic bacteriophages infecting multidrug resistant Klebsiella pneumoniae (2013) (95)
Facing Antibiotic Resistance: Staphylococcus aureus Phages as a Medical Tool (2014) (91)
Phage Therapy: What Have We Learned? (2018) (89)
Wound healing potential of topical bacteriophage therapy on diabetic cutaneous wounds (2013) (87)
Bacteriophages and transplantation tolerance. (2006) (87)
Phage therapy of staphylococcal infections (including MRSA) may be less expensive than antibiotic treatment. (2007) (82)
Antibody Production in Response to Staphylococcal MS-1 Phage Cocktail in Patients Undergoing Phage Therapy (2016) (82)
The role of cell adhesion molecules in immunopathology. (1994) (81)
Sildenafil citrate decreased natural killer cell activity and enhanced chance of successful pregnancy in women with a history of recurrent miscarriage. (2008) (79)
Is phage therapy acceptable in the immunocompromised host? (2008) (77)
Phage therapy: Current status and perspectives (2020) (76)
Challenging Futures of Science in Society. Emerging trends and cutting-edge issues (2009) (76)
New insights into the possible role of bacteriophages in host defense and disease (2003) (75)
Effects of bacteriophages on free radical production and phagocytic functions (2006) (74)
Bacteriophages in the gastrointestinal tract and their implications (2017) (71)
Eradication of Enterococcus faecalis by phage therapy in chronic bacterial prostatitis — case report (2009) (71)
Bacteriophage preparation inhibition of reactive oxygen species generation by endotoxin-stimulated polymorphonuclear leukocytes. (2008) (68)
Bacteriophage therapy for infections in cancer patients (2001) (67)
Antiphage activity of sera during phage therapy in relation to its outcome. (2017) (66)
T4 Phage and Its Head Surface Proteins Do Not Stimulate Inflammatory Mediator Production (2013) (65)
Antitumor activity of bacteriophages in murine experimental cancer models caused possibly by inhibition of beta3 integrin signaling pathway. (2004) (63)
Successful eradication of methicillin-resistantStaphylococcus aureus (MRSA) intestinal carrier status in a healthcare worker — Case report (2008) (60)
T4 Phage Tail Adhesin Gp12 Counteracts LPS-Induced Inflammation In Vivo (2016) (60)
Bacteriophages in medicine. (2007) (59)
Immunomodulating activity of heparin (1991) (59)
Rapamycin, unlike cyclosporine A, enhances suppressive functions of in vitro-induced CD4+CD25+ Tregs. (2009) (57)
A retrospective analysis of changes in inflammatory markers in patients treated with bacterial viruses (2009) (54)
Bacteriophages and cancer (2010) (52)
The biological functions of beta3 integrins. (2004) (51)
The perspectives of the application of phage therapy in chronic bacterial prostatitis. (2010) (50)
Means to Facilitate the Overcoming of Gastric Juice Barrier by a Therapeutic Staphylococcal Bacteriophage A5/80 (2017) (49)
Bacteriophage therapy in children: facts and prospects. (2008) (49)
Factors determining phage stability/activity: challenges in practical phage application (2019) (49)
In vitro design of a novel lytic bacteriophage cocktail with therapeutic potential against organisms causing diabetic foot infections. (2014) (49)
Effects of prophylactic administration of bacteriophages to immunosuppressed mice infected with Staphylococcus aureus (2009) (48)
Allotransplantation of Cultured Parathyroid Progenitor Cells Without Immunosuppression: Clinical Results (2007) (48)
The influence of immuosuppressive therapy on the development of CD4+CD25+ T cells after renal transplantation. (2007) (47)
Anticancer activity of bacteriophage T4 and its mutant HAP1 in mouse experimental tumour models. (2004) (46)
Perspectives of Phage Therapy in Non-bacterial Infections (2019) (46)
Phages in the global fruit and vegetable industry (2015) (45)
Phage Therapy: Towards a Successful Clinical Trial (2020) (45)
Phage-Phagocyte Interactions and Their Implications for Phage Application as Therapeutics (2017) (45)
Bacteriophages and Lysins in Biofilm Control (2020) (44)
Bacterial viruses against viruses pathogenic for man? (2005) (43)
Hoc protein regulates the biological effects of T4 phage in mammals (2007) (41)
The Potential of Phage Therapy in Sepsis (2017) (39)
Bacteriophages support anti-tumor response initiated by DC-based vaccine against murine transplantable colon carcinoma. (2008) (39)
The Effect of Bacteriophage Preparations on Intracellular Killing of Bacteria by Phagocytes (2015) (38)
Increased expression of adhesion molecule CD18 (LFA‐1β) on the leukocytes of peripheral blood in patients with acute ischemic stroke (1998) (37)
Effect of phage therapy on the turnover and function of peripheral neutrophils. (2002) (37)
Phages targeting infected tissues: novel approach to phage therapy. (2015) (37)
Possible association of cytotoxic T-lymphocyte antigen 4 gene promoter single nucleotide polymorphism with acute rejection of allogeneic kidney transplant. (2006) (36)
Ethics review in compassionate use (2017) (36)
Treatment of recurrent urinary tract infections in a 60‐year‐old kidney transplant recipient. The use of phage therapy (2020) (36)
Taking Bacteriophage Therapy Seriously: A Moral Argument (2014) (34)
Induction of Phage-Specific Antibodies by Two Therapeutic Staphylococcal Bacteriophages Administered per os (2019) (34)
Possible association between phages, Hoc protein, and the immune system (2006) (33)
Engineered Bacteriophage Therapeutics: Rationale, Challenges and Future (2021) (33)
Potential of Bacteriophages and Their Lysins in the Treatment of MRSA (2011) (33)
Phage Therapy in Poland – a Centennial Journey to the First Ethically Approved Treatment Facility in Europe (2020) (33)
Effect of FK506 versus cyclosporine on human natural and antibody-dependent cytotoxicity reactions in vitro. (1991) (32)
Bacteriophage interactions with phagocytes and their potential significance in experimental therapy (2009) (32)
Prospects of Phage Application in the Treatment of Acne Caused by Propionibacterium acnes (2017) (31)
Molecular imaging of T4 phage in mammalian tissues and cells (2014) (30)
A novel approach for separating bacteriophages from other bacteriophages using affinity chromatography and phage display (2013) (29)
Prophylactic effect of bacteriophages on mice subjected to chemotherapy-induced immunosuppression and bone marrow transplant upon infection with Staphylococcus aureus (2010) (28)
Apoptosis of T Cells in the First Trimester Human Decidua (1998) (28)
Bacteriophages provide regulatory signals in mitogen-induced murine splenocyte proliferation. (2003) (28)
Bacteriophages engineered to display foreign peptides may become short‐circulating phages (2019) (27)
The Potential of Phage Therapy in Bacterial Infections of the Eye (2009) (27)
In Vivo Studies on the Influence of Bacteriophage Preparations on the Autoimmune Inflammatory Process (2017) (27)
Cladribine (2-chloro-deoxyadenosine, CDA): an inhibitor of human B and T cell activation in vitro. (1993) (27)
New insights into the possible role of bacteriophages in transplantation. (2003) (27)
Rapid multiparameter analysis of cell stimulation in mixed lymphocyte culture reactions. (1977) (26)
Cyclolinopeptide: a novel immunosuppressive agent with potential anti-lipemic activity. (2001) (26)
Cell culture preparation of human parathyroid cells for allotransplantation without immunosuppression. (1996) (25)
Immunomodulatory action of human recombinant erythropoietin in man. (1993) (25)
Allotransplantation of cultured human parathyroid cells: present status and perspectives. (1997) (25)
Phage Therapy: Beyond Antibacterial Action (2018) (24)
Compassionate use of unauthorized drugs: Legal regulations and ethical challenges. (2019) (24)
T4 bacteriophage-mediated inhibition of adsorption and replication of human adenovirus in vitro. (2015) (23)
Delivering phage therapy per os: benefits and barriers (2017) (23)
Current Updates from the Long-Standing Phage Research Centers in Georgia, Poland, and Russia (2021) (22)
Phages in the fight against COVID-19? (2020) (22)
Investigations of cellular glucose transport and its regulation under the influence of insulin in human peripheral blood lymphocytes. (2010) (21)
Effect of FK506 and cyclosporine on primary and secondary skin allograft survival in mice. (1990) (21)
Intravenous Immunoglobulin Therapy Influences T cell Adhesion to Extracellular Matrix in Women with a History of Recurrent Spontaneous Abortions (2000) (21)
Bacteriophages displaying anticancer peptides in combined antibacterial and anticancer treatment. (2014) (21)
Leukocyte migration inhibitory factor (LMIF) induced by concanavalin A: standardized microassay for production in vitro. (1975) (20)
Selenium-containing polysaccharides from Lentinula edodes-Biological activity. (2019) (19)
Specific and Selective Bacteriophages in the Fight against Multidrug-resistant Acinetobacter baumannii (2019) (19)
Circulating Suppressor Cells in Aplastic Anemia (1979) (19)
The effect of bacteriophages T4 and HAP1 on in vitro melanoma migration (2009) (19)
The effects of T4 and A3/R phage preparations on whole-blood monocyte and neutrophil respiratory burst. (2010) (19)
First Successful Pregnancy after Addition of Enoxaparin to Sildenafil and Etanercept Immunotherapy in Woman with Fifteen Failed IVF Cycles – Case Report (2010) (19)
Immunosuppressive action of low-dose heparin. Effect on skin allograft survival. (1990) (19)
Phage-specific diverse effects of bacterial viruses on the immune system (2019) (18)
2-Chloro-2-deoxyadenosine--a novel immunosuppressive agent. (1993) (18)
The impact of pretransplant erythropoietin therapy on late outcomes of renal transplantation. (2003) (18)
Bacteriophages targeting intestinal epithelial cells: a potential novel form of immunotherapy (2017) (18)
Phage translocation, safety and immunomodulation. (2012) (17)
Activity of bacteriophages in murine tumor models depends on the route of phage administration. (2005) (17)
Phage penetration of eukaryotic cells: practical implications (2019) (17)
Effect of FK-506 and cyclosporine on human T and B lymphoproliferative responses. (1990) (17)
Ethics codes and use of new and innovative drugs (2019) (17)
Phage Therapy in Prostatitis: Recent Prospects (2018) (16)
The effect of azathioprine on terminal differentiation of human B lymphocytes. (1983) (16)
Pregnancy following kidney transplantation: risk for offsprings. (1997) (16)
Fusion to cell-penetrating peptides will enable lytic enzymes to kill intracellular bacteria. (2010) (16)
The fall and rise of phage therapy in modern medicine (2019) (16)
A3R Phage and Staphylococcus aureus Lysate Do Not Induce Neutrophil Degranulation (2017) (16)
The Biological Functions of β 3 Integrins ( β 3 integrins / α IIb β 3 integrin / α v β 3 integrin / biological functions ) (2005) (15)
Extracellular matrix proteins, regulators of T-cell functions in healthy and diseased individuals (1995) (15)
Molecular modification of T4 bacteriophage proteins and its potential application — Review (2009) (15)
Depressed immune surveillance against cancer: role of deficient T cell: extracellular matrix interactions. (1994) (15)
Bacteriophages and antibiotic interactions in clinical practice: what we have learned so far (2022) (15)
Perspectives of Phage–Eukaryotic Cell Interactions to Control Epstein–Barr Virus Infections (2018) (14)
The concerted action of lactoferrin and bacteriophages in the clearance of bacteria in sublethally infected mice. (2008) (14)
The Role of Antibiotic Resistant A. baumannii in the Pathogenesis of Urinary Tract Infection and the Potential of Its Treatment with the Use of Bacteriophage Therapy (2021) (14)
Abnormal B-cell function in hemophiliacs treated with cryoprecipitate and factor VIII and IX concentrates. (1986) (14)
Etanercept immunotherapy in women with a history of recurrent reproductive failure. (2012) (14)
Cultured parathyroid cell transplantation without immunosuppression in the treatment of surgical hypoparathyroidism. (1994) (14)
T cell interactions with extracellular matrix proteins in patients with thyroid-associated ophthalmopathy. (1998) (14)
Oral heparin in the treatment of rheumatoid arthritis. (1995) (13)
Therapeutic potential of phages in autoimmune liver diseases (2018) (13)
Phages as a Cohesive Prophylactic and Therapeutic Approach in Aquaculture Systems (2020) (13)
Effects of sildenafil citrate and etanercept treatment on TNF-α levels in peripheral blood of women with recurrent miscarriage. (2015) (13)
Bacteriophage Interactions With Epithelial Cells: Therapeutic Implications (2021) (13)
Animal Models in the Evaluation of the Effectiveness of Phage Therapy for Infections Caused by Gram-Negative Bacteria from the ESKAPE Group and the Reliability of Its Use in Humans (2021) (13)
Immune Response to Therapeutic Staphylococcal Bacteriophages in Mammals: Kinetics of Induction, Immunogenic Structural Proteins, Natural and Induced Antibodies (2021) (12)
Enzybiotics and their Potential Applications in Medicine (2009) (12)
Influence of bacteriophage preparations on intracellular killing of bacteria by human phagocytes in vitro. (2013) (12)
Leukocyte migration inhibitory factor (LMIF) profile in primary and secondary immunodeficiency disease. (1976) (12)
Phage therapy in allergic disorders? (2018) (12)
Leukocyte migration inhibitory factor (LMIF) production in unidirectional mixed lymphocyte cultures. (1976) (12)
Possible Use of Bacteriophages Active against Bacillus anthracis and Other B. cereus Group Members in the Face of a Bioterrorism Threat (2014) (12)
Enhanced T cells interactions with extracellular matrix proteins in infertile women with endometriosis. (2002) (11)
Disturbances of T‐cell interactions with endothelium and the extracellular matrix proteins in a patient with Takayasu arteritis (1994) (11)
Cultured parathyroid cells allotransplantation without immunosuppression for treatment of intractable hypoparathyroidism. (1996) (11)
Can phage therapy solve the problem of recalcitrant chronic rhinosinusitis? (2017) (11)
Superiority of corpuscular BCG to soluble PPD antigen in the leucocyte migration assay. (1974) (11)
Natural and Induced Antibodies Against Phages in Humans: Induction Kinetics and Immunogenicity for Structural Proteins of PB1-Related Phages. (2020) (11)
HLA antigens and intracranial aneurysms (2005) (11)
Biological Properties and Clinical Use of Calf Thymus Extract TFX-Polfa (1984) (10)
Alterations of T-cell: extracellular matrix proteins interactions in psoriasis. (1993) (10)
Clinical results of human cultured parathyroid cell allotransplantation in the treatment of surgical hypoparathyroidism. (1996) (10)
The effects of bacteriophages on the expression of genes involved in antimicrobial immunity* (2019) (10)
Human immunodeficiency disease: impairment of cellular interactions leading to abnormal mediator production in mixed lymphocyte culture reaction. (1977) (10)
Thymosin: an immunomodulator of antibody production in man. (1982) (10)
The effects of staphylococcal bacteriophage lysates on cancer cells in vitro (2010) (10)
Low dose heparin: efficacious treatment for chronic renal allograft rejection. (1993) (9)
Human β-Defensin 2 and Its Postulated Role in Modulation of the Immune Response (2021) (9)
The Effects of T4 and A3/R Bacteriophages on Differentiation of Human Myeloid Dendritic Cells (2016) (9)
Phage Therapy in Orthopaedic Implant-Associated Infections (2019) (9)
New strategies of heparin treatment used to prolong allograft survival. (1991) (9)
Abnormalities in T cell interactions with the extracellular matrix proteins in a patient with Wegener's granulomatosis. (1993) (9)
Anti-phage serum antibody responses and the outcome of phage therapy (2020) (9)
“Phage Transplantation in Allotransplantation”: Possible Treatment in Graft-Versus-Host Disease? (2018) (8)
Phages in Therapy and Prophylaxis of American Foulbrood – Recent Implications From Practical Applications (2020) (8)
An optimal assay of human B cell proliferation in vitro. (1987) (8)
Enhanced clonability of human T lymphocytes caused by their culturing in vitro. (1981) (8)
Toll-Like Receptor 4 Gene Polymorphism C1196T in Polish Women with Postmenopausal Osteoporosis - Preliminary Investigation. (2015) (8)
Cellular glucose transport disturbances as a marker of the pre-diabetic state - pathogenetic and clinical significance of the assessment of GLUT4 expression. (2010) (8)
Low‐dose heparin: a novel approach in immunosuppression (1994) (8)
[Bacterial translocation and its clinical significance]. (2005) (8)
Ethics codes and medical decision making. (2020) (8)
The Presence of Bacteriophages in the Human Body: Good, Bad or Neutral? (2020) (8)
Humoral Immune Response to Phage-Based Therapeutics (2019) (8)
Phage Prevalence in the Human Urinary Tract—Current Knowledge and Therapeutic Implications (2020) (8)
Inhibitory Effects of Bacteriophage Preparations on Adenoviral Replication (2019) (8)
Adhesion molecule expression stimulated by Bacteroides thetaiotaomicron cell-surface antigens. (1999) (8)
Abnormal T-cell costimulation by proteins of the extracellular matrix in human renal allografting. (1993) (7)
The Potential Dual Use of Online Pharmacies (2010) (7)
Increased mRNA expression of transforming growth factor beta in the arterial wall of chronically rejected renal allografts in humans. (2006) (7)
Application of microbiological quantitative methods for evaluation of changes in the amount of bacteria in patients with wounds and purulent fistulas subjected to phage therapy and for assessment of phage preparation effectiveness (in vitro studies). (2013) (7)
Sustaining progress in the life sciences: strategies for managing dual use research of concern--progress at the national level. (2009) (7)
Legal regulations, ethical guidelines and recent policies to increase transparency of clinical trials (2020) (7)
The effect of calf thymus extract (TFX) on human and mouse hemopoiesis. (1981) (7)
Anti‐Staphylococcal Lytic Enzymes (2009) (7)
"Medical writing" and ghostwriting as ethical challenges in medical communication. (2010) (7)
The Rationale for Using Bacteriophage to Treat and Prevent Periprosthetic Joint Infections (2020) (7)
Temperate Bacteriophages—The Powerful Indirect Modulators of Eukaryotic Cells and Immune Functions (2021) (7)
LPS-Activated Monocytes Are Unresponsive to T4 Phage and T4-Generated Escherichia coli Lysate (2016) (7)
Beta 3 integrin expression on T cells from renal allograft recipients. (2006) (7)
Microbiota in organ transplantation: An immunological and therapeutic conundrum? (2020) (6)
Human T cell adhesion to endothelium stimulated by membrane components extracted from strains of Bacteroides vulgatus (member of B. fragilis group). (1993) (6)
Rejection-associated abnormalities of T-cell interactions with extracellular matrix. (1995) (6)
Influence of clindamycin, metronidazole and polymyxin B on the expression of cell adhesion molecules stimulated by endotoxin and enterotoxin of Bacteroides fragilis. (2003) (6)
The effect of ampicillin on the expression of Fc-IgG receptors on human peripheral blood lymphocytes. (1981) (6)
Effect of FK 506 on B-cell responses. (1991) (6)
Modulation of CD3-dependent lymphocyte proliferation by extracellular matrix proteins in atopic dermatitis. (1995) (6)
Phage therapy of wound-associated infections (2022) (6)
[The presence of bacteriophages in human feces and their potential importance]. (2006) (6)
Editorial: Advances in Phage Therapy: Present Challenges and Future Perspectives (2021) (6)
Use of a Regression Model to Study Host-Genomic Determinants of Phage Susceptibility in MRSA (2018) (6)
Alloantigen-activated lymphocyte colony formation in semisolid agar. (1979) (6)
T cell adhesion to the extracellular matrix proteins as a determinant of pregnancy success or failure. (1998) (6)
Low Immunogenicity of Intravesical Phage Therapy for Urogenitary Tract Infections (2021) (5)
Intracellular localization of synthesized immunoglobulins in B cells: a modified method. (1983) (5)
Thymosin/TFX/stimulates t-helper cells immunoglobulin/Ig/synthesis in vitro (1982) (5)
Successful pregnancy after Intralipid addition to sildenafil and enoxaparin in woman with history of recurrent pregnancy loss (RPL). (2016) (5)
The contribution of phage therapy to medical knowledge. (2022) (5)
Human peripheral blood CD8+ CD28- T cells of renal allograft recipients do not express FOXP3 protein. (2011) (5)
Evidence that cyclophosphamide is a strong inhibitor of human B cell proliferation. (1987) (5)
Polysaccharide and lipid components of Bacteroides thetaiotaomicron lipopolysaccharide as stimulators of endothelial adhesion molecule expression (1999) (5)
374 PATHOGEN ERADICATION BY PHAGE THERAPY IN PATIENTS WITH CHRONIC BACTERIAL PROSTATITIS (2010) (5)
Oral heparin prolongs survival of skin allografts. (1991) (5)
Murine spleen leukocytes as an inhibitable target cell system for human MIF. (1974) (5)
Statins inhibit T-cell interactions with elastin. (1999) (5)
[Immunomodulating effect of blood transfusion]. (1987) (5)
Autoimmune neutropenia after renal transplantation. (1989) (5)
Therapeutic Perspectives and Mechanistic Insights of Phage Therapy in Allotransplantation. (2020) (5)
Normal B cell compartment in chronic lymphatic leukemia (2006) (4)
Increased content of fibronectin and laminin in glomeruli isolated from chronically rejected human renal allografts. (1996) (4)
Addendum: Kaźmierczak, Z.; Górski, A.; Dąbrowska, K. Facing Antibiotic Resistance: Staphylococcus aureus Phages as a Medical Tool. Viruses 2014, 6, 2551-2570. (2015) (4)
Corticosteroid-dependent alterations of human myelopoiesis in vitro. (1979) (4)
Nec Soli Cedit (article dedicated to Professor Ludwik Hirszfeld). (2005) (4)
Conflict of interest and its significance in science and medicine (2002) (4)
Heparin and platelet interactions influence alloantigen-induced proliferative responses of human T lymphocytes and immunoglobulin synthesis in vivo. (1991) (4)
T-cell apoptosis following renal transplantation. (1998) (4)
The long-term outcome of renal transplantation. A 10-year follow-up of 765 recipients. (2019) (4)
The effects of T4 and A5/80 phages on the expression of immunologically important genes in differentiated Caco-2 cells* (2020) (4)
Bacteriophage Pharmacology and Immunology (2021) (4)
Immune biomarkers and long‑term graft survival: a prospective follow‑up of 457 kidney transplant recipients. (2017) (4)
The modification of peripheeral leukocyte-migration test using preincubation with specific antigen. (1973) (4)
Is gastric cancer heterogeneity the clue to HLA-DR associated susceptibility? (1994) (4)
Mutations in bacteriophage T4 genome. (2002) (4)
Isolation and Characterization of Phages Active against Paenibacillus larvae Causing American Foulbrood in Honeybees in Poland (2021) (4)
Antitumor effect of combined treatment of mice with cytostatic agents and bacteriophage T4. (2009) (4)
Cellcept enhances the rate of apoptosis in T cells after renal transplantation. (1999) (4)
Building the Prestige of Archivum Immunologiae et Therapiae Experimentalis: From a Little Known to an Internationally Recognized Journal (2018) (4)
Sepsis, Phages, and COVID-19 (2020) (4)
Identification of the Primary Structure of Selenium-Containing Polysaccharides Selectively Inhibiting T-Cell Proliferation (2021) (4)
Corrigendum: Bacteriophage Procurement for Therapeutic Purposes (2016) (4)
Influence of bacteriophage preparations on migration of HL-60 leukemia cells in vitro. (2013) (4)
[Osteoimmunology: new area of research on the associations between the immune and bone systems]. (2001) (3)
Ethics framework for treatment use of investigational drugs (2020) (3)
Migration inhibition test based on the culture of spleen fragments: a quantitative analysis. (1972) (3)
[Phage-display technology and its application to experimental oncological therapy]. (2004) (3)
Structure of Post-Transplant Care in a Single Transplant Center. (2016) (3)
Potential for Phages in the Treatment of Bacterial Sexually Transmitted Infections (2021) (3)
Prolongation of cardiac allograft survival in rats following combination treatment with 2-chloro-2'-deoxyadenosine and cyclosporine: a novel immunosuppressive strategy. (1996) (3)
HIV-protein-mediated alterations in T cell interactions with the extracellular matrix proteins and endothelium. (1997) (3)
[Some aspects of immune response in toxoplasmosis]. (2001) (3)
[The potential use of bacteriophages in view of the current antibiotic therapy crisis]. (2005) (3)
Role of adhesion molecules in chronic allograft rejection. (1999) (3)
Allogeneic sensitization alters T-cell reactivity to extracellular matrix proteins in prospective transplant recipients. (1995) (3)
IMMUNOMODULATING INFLUENCE OF ACTIVE METABOLITE OF CYCLOPHOSPHAMIDE ON HUMAN LYMPHOCYTE IMMUNOGLOBULIN BIOSYNTHESIS IN VITRO (1983) (3)
[The immunobiological effects of nitrogranulogen. I. Effect of nitrogranulogen on laboratory and clinical parameters in patients with primary glomerulopathies]. (1991) (3)
The ethics of intellectual property rights in biomedicine and biotechnology: An introduction (2005) (3)
[The immunobiological effects of nitrogranulogen. I. Summarizing the results of the immunological studies to date]. (1991) (3)
A Thorough Synthesis of Phage Therapy Unit Activity in Poland—Its History, Milestones and International Recognition (2022) (3)
SILDENAFIL UPREGULATES TUMOR NECROSIS FACTOR α PRODUCTION IN PERIPHERAL BLOOD MONONUCLEAR CELLS OF HEALTHY MEN - PRELIMINARY REPORT (2019) (3)
Transient hypogammaglobulinemia of infancy. (1982) (3)
The responsible conduct of basic and clinical research (2006) (3)
[Olfactory glial cells: hope in the treatment of spinal cord injuries]. (2004) (3)
The effect of uremia and dialysis on cell-mediated immunity. (1978) (3)
Nitrogranulogen enhances IL-1 production but decreases cellular sensitivity to this cytokine. (1991) (3)
Value of urine sediment phenotyping in renal allograft recipients. (1993) (3)
Two Newly Isolated Enterobacter-Specific Bacteriophages: Biological Properties and Stability Studies (2022) (3)
Anti-biofilm activity of bacteriophages and lysins in chronic rhinosinusitis. (2021) (3)
Organ transplantation at the Medical University of Warsaw. (2005) (3)
[Immunology of ulcerative colitis--interactions of T lymphocytes with extracellular matrix proteins]. (1997) (3)
Vitamin D receptor gene polymorphism in Polish patients with morbid obesity (2013) (2)
Extracellular Matrix Protein‐dependent Apoptosis of T Cells in Women with a History of Recurrent Spontaneous Abortion (2002) (2)
Nitrogranulogen-dependent inhibition of antibody synthesis. I. In vitro studies in man. (1991) (2)
Upregulation of elastin-mediated costimulation of T-cell responses after renal transplantation. (1997) (2)
Neutrophil functions in renal transplant recipients. (1978) (2)
Influence of bacteriophage preparations on migratory activity of human granulocytes in vitro (2014) (2)
Nitrogranulogen: a strong inhibitor of human lymphocyte proliferation. (1989) (2)
Adhesion molecules in allergic disease, B.S. Bochner, Marcel Dekker (Eds.) (1997), 419, $175.00 (1998) (2)
T-cell interactions with extracellular matrix proteins in periodontal disease. (1998) (2)
Immunoregulatory factors controlling terminal differentiation of malignant B-lymphocytes. (1983) (2)
γδ+ T cells in Wilson's diseaseT cells in Wilson's disease (1996) (2)
The range and sensitivity of migration inhibition test used for estimation of antigenicity of splenic microsomal fraction. (1969) (2)
IgA nephropathy: a long-term progressive study. (1990) (2)
Bronisława Fejgin (1883–1943): Forgotten Important Contributor to International Microbiology and Phage Therapy (2021) (2)
Cellular immunity in man assessed by indirect migration inhibition test using murine spleen leukocytes. (1973) (2)
Lymphocyte interactions with extracellular matrix proteins and endothelium in renal allograft recipients. (1998) (2)
T-cell interactions with extracellular matrix proteins and endothelium in chronic renal allograft rejection. (1997) (2)
Effects of bacteriophages on clearance of Pseudomonas aeruginosa and Staphylococcus aureus and serum cytokine levels in infected mice (2007) (2)
Nitrogranulogen-dependent inhibition of antibody synthesis. II. In vivo studies in mice. (1991) (2)
Heparin enhances generation of natural killer activity in vitro. (1994) (2)
Colony-stimulating factor production and secretion following renal transplantation. (1979) (2)
HUMAN PAPILLOMAVIRUS AS A RISK FACTOR FOR DEVELOPMENT OF CANCER IN ALLOGRAFT RECIPIENTS (2004) (2)
Graft infiltrating t-lymphocyte expression of CD26, CD29, and CD49e molecules and genes. (2000) (2)
[Effect of clindamycin on stimulation of cell adhesion molecules by endotoxins and enterotoxin of Bacteroides fragilis strains]. (2001) (2)
Gamma delta + T cells in Wilson's disease. (1996) (2)
Flow cytometry crossmatch in living donor renal transplantation. (2002) (2)
Bacteriophage Inhibits Metastasis in Mouse Transplantable Melan (2004) (2)
Class II antigens and interleukin 2 expression in renal allograft recipients. (1989) (2)
Thymosin (TFX) and suppressor cells of immunoglobulin (Ig) production in man. (1983) (2)
My remembrance of Professor Tadeusz Orłowski. (2009) (2)
Expression of FasL gene in T cells of renal allograft recipients. (2002) (2)
Journal Impact Factor and Self-Citations (2021) (2)
Conflicts of interest in oncology expanded access studies (2021) (2)
In vitro proliferation of hematopoietic stem cells circulating in blood of patients with kidney allografts. (1978) (1)
Role of extracellular matrix proteins in organ transplantation. (1997) (1)
Evaluation of bone mass in insulin dependent diabetes during ultrasonic examination (1995) (1)
Genetic control of mediator production in human MLC. (1977) (1)
Inhibition of human B lymphocyte differentiation by a stable metabolite of cyclophosphamide (ASTA Z 7557, INN mafosfamide) (2004) (1)
Diminished synthesis of immunoglobulins by lymphocytes of patients treated with thymosin (TFX) and cyclophosphamide. (1983) (1)
Blood transfusion induces alterations in the circulation of immunoglobulin-secreting cells and activates helper T cells for Ig synthesis. (1987) (1)
Excessive costimulation of CD3-dependent lymphocyte response by extracellular matrix proteins in severe widespread psoriasis (2005) (1)
[Immunosuppressive effect of heparin]. (1990) (1)
Cladribine (2-chloro-2'-deoxyadenosine): new perspectives in clinical immunosuppression. (1994) (1)
[Successful nitrogranulogen treatment of severe nephrotic syndrome in glomerulonephritis--case report]. (1992) (1)
Deficiency of short-lived suppressor cells controlling T-lymphocyte colony formation in acute lymphoblastic leukemia. (1983) (1)
Megakaryocyte precursor cells circulating in blood of a renal transplant recipient with thrombocytosis. (1981) (1)
Immunosuppression inhibits switch from naive to memory phenotype in human T lymphocytes. (1991) (1)
Immune monitoring after renal transplantation. II. Post-transplant disturbances in the CD3 complex expression may be caused by immunosuppression. (1991) (1)
Bacteriophages targeting intestinal epithelial cells: a potential novel form of immunotherapy (2017) (1)
ClinicalTrials.gov as a Source of Information About Expanded Access Programs: Cohort Study (2021) (1)
Efficacy of a new treatment for chronic rejection: thymic hormones with immunosuppression. (1989) (1)
Significance of HLA matching in renal transplantation from living donors. (1996) (1)
Public availability of results of ClinicalTrials.gov‐registered expanded access studies (2021) (1)
Class II antigen and interleukin-2 expression in renal allograft recipients. (1989) (1)
Diminished integrin expression on granulocytes from renal allograft recipients. (1992) (1)
[Allotransplantation of the parathyroid in patients without immunosuppression]. (1995) (1)
What Are the Potential Benefits of Using Bacteriophages in Periodontal Therapy? (2022) (1)
Conflict of interest and its significance in science and medicine: A view from eastern Europe (2001) (1)
Adhesive molecules - current concepts in medicine (1997) (1)
In vitro humoral responses of renal allograft recipients. (1987) (1)
Do Anti-Phage Antibodies Persist after Phage Therapy? A Preliminary Report (2022) (1)
Lymphocyte adhesion molecules in renal allograft rejection. (1996) (1)
[Stimulation of adhesion molecules on vascular endothelium by capsular polysaccharide, lipopolysaccharide and components of lipopolysaccharide from Bacteroides thetaiotaomicron]. (2000) (1)
Involvement of beta2-microglobulin in CD69 expression on T cells. (2001) (1)
UNILATERAL LMIF PRODUCTION IN MLC REACTION AS A MEASURE OF IMMUNOCOMPETENCE IN IMMUNODEFICIENCY DISEASES (1977) (1)
Correction to: Building the Prestige of Archivum Immunologiae et Therapiae Experimentalis: From a Little Known to an Internationally Recognized Journal (2018) (1)
Effect of azanthioprine on allograft sensitivity. Study of spleen cell migration. (1969) (1)
Biological Properties of 12 Newly Isolated Acinetobacter baumannii-Specific Bacteriophages (2023) (1)
Expanded access: growing importance to public health (2018) (1)
Can the immunosupressive effect of perioperative single high-dose antithymocyte globulin administration in kidney allograft recipients be due to apoptosis of activated lymphocytes ? (2002) (1)
[Current clinical application of bacteriophages and perspectives for their genetic modifications]. (2001) (1)
[Pregnancy outcome in the woman with antiphospholipid antibodies: a case report]. (2000) (1)
[Adhesion of human granulocytes and T lymphocytes to vascular endothelial cells after stimulation with Bacteroides fragilis endotoxin and enterotoxin]. (2001) (1)
Polish Contribution to the Advancement of Phage Treatment in Humans (2020) (1)
Intracellular cytokine production in chronic renal allograft rejection. (2002) (1)
The effect of cyclophosphamide derivatives on cellular cytotoxicity (NK, ADCC) in vitro. (1990) (1)
[Toxins of Bacteroides fragilis and Bacteroides thetaiotaomicron rods as stimulators of adhesion molecule expression on the surface of vascular endothelial cells]. (1999) (1)
Editorial review: Apoptosis and its role in immunity (1996) (1)
The role of immunopathologic factors in hematopoietic disorders. (1981) (0)
Graft-induced polyclonal activation of B cells. I. Alloantigen-induced humoral response in mice. (1987) (0)
[Present-day views on the physiopathology of the macrophage-monocyte system]. (1977) (0)
The inï¬‚uence of cyclosporine a and rapamycin on the expression of CD11b and CD57 within CD8+CD28- population in renal allograft recipients (2009) (0)
Comparison of two modifications of indirect migration inhibition test-murine spleen fragment and capillary tube migration assays. (1973) (0)
[ICAM-3, the role and significance of leukocyte interactions]. (1996) (0)
Journal Impact Factor and Self-Citations (2021) (0)
[Migration inhibition test in clinical diagnostics]. (1972) (0)
NOTESNOTES I . O . 4 Construction and characterization of T 4-like phages lacking head proteins gp 24 orgpSoc (2015) (0)
Interleukin 2 receptor positive T lymphocytes in renal allograft recipients: association with CMV infection. (1991) (0)
DRB polymerase chain reaction fingerprinting, DQA oligotyping and mixed lymphocyte culture results in related bone marrow donors and recipients. (1995) (0)
Effect of viral infection on T-cell apoptosis in allograft recipients. (2000) (0)
[Monitoring cellular immunity in patients following renal transplantation]. (1972) (0)
The preliminary association study of osteopontin 707 C/T polymorphism with systemic lupus erythematosus in a Polish population (2020) (0)
Graft-induced polyclonal activation of B cells. II. Humoral response of renal allograft recipients (RAR). (1987) (0)
Extracellular matrix proteins dependent apoptosis of T Cells in women with a history of recurrent spontaneous abortion (2002) (0)
The influence of thymosin (TEX) on antigen-induced primary and secondary antibody responses of mice. (1985) (0)
Effect of anti-class II and interleukin-2 receptor (R-IL2) monoclonal antibodies (MoAb) on B cell responses in vitro (1988) (0)
Cell-mediated response in different forms of human toxoplasmosis (1998) (0)
Lymphokine-supressing cells in patients after kidney transplantation. (1978) (0)
[Vasculitis--new etiopathogenic and clinical aspects]. (1995) (0)
The effect of TFX on antigen-induced antibody production in mice (1982) (0)
Detection and Level Evaluation of Antibodies Specific to Environmental Bacteriophage I11mO19 and Related Coliphages in Non-Immunized Human Sera (2023) (0)
Clinical immunobiology: facts and prospects. (1976) (0)
FOXP3, CD11B AND CD57 - LOOKING FOR MARKERS OF SUPRESSOR SUBSET OF CD8+CD28- CELLS FROM RENAL ALLOGRAFT RECIPIENTS: 1451 (2008) (0)
[Immunotherapy and gene therapy of neoplasms]. (1993) (0)
Statins as immunomodulatory drugs. (2001) (0)
Building the Prestige of Archivum Immunologiae et Therapiae Experimentalis: From a Little Known to an Internationally Recognized Journal (2018) (0)
Pretransplant blood transfusion with cyclophosphamide: efficacious means of prolonging allograft survival. (1991) (0)
Introduction: the responsible conduct of basic and clinical research. (2006) (0)
Bacteriophages and Lysins in Biofilm Control (2020) (0)
[Advances in transplantology. Bone marrow transplantation]. (1976) (0)
Specific and Selective Bacteriophages in the Fight against Multidrug-resistant Acinetobacter baumannii (2019) (0)
Influence of antisperm antibodies on T cell adhesion to extracellular matrix proteins in women with a history of unexplained infertility. (2001) (0)
Ethics framework for treatment use of investigational drugs (2020) (0)
[Role of lymphocyte subpopulations in proliferative diseases of the lymphoid system]. (1976) (0)
[Present-day problems of immunotherapy: transfer factor and levamisole]. (1976) (0)
Potential application of bacteriophages in bacterial infections in animals. (2006) (0)
S. aureus-induced B cell proliferation as a model for studying the effectiveness of immunosuppressive agents. (1987) (0)
Immunity to virus infection (excluding retroviruses) (PP-025) (2010) (0)
[Co-stimulating effect of extracellular matrix proteins on T lymphocyte proliferation in patients with sarcoidosis. Preliminary tests]. (1996) (0)
Immunomodulating effects of heparin on human B cell proliferation. (1993) (0)
Dura Lex, Sed Lex – Retirement Age (2016) (0)
The Role of the Virome in the Gut-Liver Axis (2018) (0)
[In vitro biosynthesis of antibodies. II. Disorders of antibody biosynthesis and associated clinical syndromes]. (1982) (0)
Glucosteroid (GS)-dependent immunomodulation of immunoglobulin biosynthesis in vitro. III. Effect of GS on helper and suppressor cells' Ig production in vitro. (1987) (0)
[The role of immune mechanisms in the pathogenesis of atherosclerosis]. (2001) (0)
Dual effect of transplantation immunity on lymphocyte and granulocyte progenitors. (1983) (0)
[Cellular immunity in women in normal pregnancy and puerperium]. (1977) (0)
The inﬂuence of cyclosporine a and rapamycin on the b cell subpopulations in vitro (2009) (0)
Immunoglobulin synthesis by lymphocytes of eight immuno-deficient children. (1985) (0)
Apoptosis of T cells in the first trimester human trophoblast during abortion process (1997) (0)
Stimulation and inhibition of hematopoiesis by the MLC reaction. (1981) (0)
[Immunoprofile of LMIF in immunologic deficiency syndromes. II. Mediator production by isolated subpopulations of human lymphocytes]. (1978) (0)
T-cell interactions with extracellular matrix proteins in allograft rejection: target for immunomodulating therapy. (1996) (0)
The engagement of Polish Academy of Sciences in domestic and international activities related to the dilemma of dual use (2010) (0)
Cell-mediated response in nodular and ocular forms of human toxoplasmosis (1998) (0)
[Advances in internal immunology: transfer of cellular immunity. Clinical problems in theory and practice]. (1973) (0)
[Stimulation of adhesion molecule expression in human vascular endothelium by Bacteroides fragilis toxins--influence of polymyxin B]. (2002) (0)
novel strains of bacteriophages for treating bacterial infections, especially resistant strains of Enterococcus (2009) (0)
THE INFLUENCE OF VIRAL INFECTIONS ON INTRACELLULAR CYTOKINE SYNTHESIS BY T CELLS OF RENAL ALLOGRAFT RECIPIENTS (2004) (0)
[The evaluation of expression of T-lymphocytes and NK cell surface receptors in women with threatened miscarriage]. (1998) (0)
[Cellular cytotoxicity in the studies of immunosuppressive activity of drugs]. (1988) (0)
[Effect of tissue transplantation on the hematopoietic system]. (1979) (0)
Treatment of recurrent urinary tract infections in a 60-year-old kidney transplant recipient – last-chance antibiotics and phage therapy (2019) (0)
[Will the third millenium fulfill expectations for the role of molecular biology, genetics and immunology in medicine?]. (2001) (0)
Promethazine (P): A new immunosuppressant with strong anti-B cell and class II antigen activity (1988) (0)
Glucosteroid (GS)-dependent immunomodulation of immunoglobulin biosynthesis in vitro. II. Effect of GS on mitogen- and alloantigen-induced Ig synthesis. (1987) (0)
The T-cell apoptosis in the early period after renal allograft transplantation. (2002) (0)
[Monitoring of the humoral response in clinical immunology]. (1984) (0)
[The effect of metronidazole on stimulation of adhesion molecule expression on the surface of vascular endothelial cells by Bacteroides fragilis endotoxins and enterotoxin]. (2001) (0)
Decreased NK cell activity after partial vulvectomy in pregnant patient with vulvar intraepithelial neoplasia 3 (VIN3). (2017) (0)
[Characteristics of cell membrane of B-lymphocytes in chronic lymphocytic leukemia. I. Expression of class II antigens (HLA-D)]. (1991) (0)
[The role of components of peritoneal fluid in the immunopathogenesis of endometriosis]. (2001) (0)
Can the immunosuppressive [correction of immunosupressive] effect of perioperative single high-dose antithymocyte globulin administration in kidney allograft recipients be due to apoptosis of activated lymphocytes? (2002) (0)
P195 The Presence of Escherichia Coli Bacteriophages in Human Stool of Patients with Inflammatory Bowel Disease (2007) (0)
[Role of immunologic mechanisms in aplastic anemia]. (1978) (0)
A process for preparing polyvalent bakteriophagenpräparationen for treating bacterial infections (2002) (0)
Reply to “Innovation and off‐label use, the French case and more” by Braillon and Lexchin (2019) (0)
Rejection-associated upregulation of the alpha/beta-T cell receptor expression on T cells of renal allograft recipients. (1990) (0)
Placebo: its action and place in health research today. (2004) (0)
Correction to: Building the Prestige of Archivum Immunologiae et Therapiae Experimentalis: From a Little Known to an Internationally Recognized Journal (2018) (0)
Psychic advantages of recreation and leisure tourism. (1992) (0)
Quality and Safety Requirements for Sustainable Phage Therapy Products (2015) (0)
How Interest in Phages Has Bloomed into a Leading Medical Research Activity in Poland (2022) (0)
Introduction to the proceedings of an international conference Placebo: Its action and place in health research today Warsaw, Poland, 12–13 April, 2003 (2004) (0)
The advancement of science and the dilemma of dual use: why we can't afford to fail. Proceedings of a conference. November 9-10, 2007. (2010) (0)
ClinicalTrials.gov as a source of information about expanded access programs: a cohort study (Preprint) (2021) (0)
Large granular lymphocyte lymphocytosis with neutropenia: a case report. (1989) (0)
Prof. Orłowski’s contribution to the achievement of high professional and ethical standards in the medical sciences in Poland (2009) (0)
Semi-Automatic Contacting System 'GR-1' in Marine Radios, (1982) (0)
Characterising the biology of novel lytic bacteriophages infecting multidrug resistant Klebsiella pneumoniae (2013) (0)
The report on the activity of the Commission on Ethics in Science in the year 2018 (2019) (0)
AITE Celebrates Its 70th Year of Publication (1953–2022) (2021) (0)
Vitamin D receptor gene polymorphism in Polish patients with morbid (2014) (0)
Abnormalities in T-cell-ECM interactions in cancer. (1996) (0)
Characteristics of Environmental Klebsiella pneumoniae and Klebsiella oxytoca Bacteriophages and Their Therapeutic Applications (2023) (0)
Ethics of Phage Therapy (2019) (0)
Abnormal Adhesion of T Cells to Extracellular Matrix Proteins in Hemodialysis Patients (1998) (0)
THE PRESENCE OF ESCHERICHIA COLI BACTERIOPHAGES IN HUMAN STOOL OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE (2007) (0)
[Thymosin in the treatment of hypo- and aplastic anemia in children]. (1985) (0)
Anti-phage serum antibody responses and the outcome of phage therapy (2020) (0)
Immunosuppressive drugs inhibit class II antigen (HLA-D) synthesis by B and T lymphocytes. (1990) (0)
[Cryptococcosis in patients with transplanted kidney treated with steroids and azathioprine]. (1988) (0)
[Immunoprofile of LMIF in immunologic deficiency syndromes. I. Lymphocytes suppressing lymphokines in mixed lymphocyte culture]. (1978) (0)
TFX modulates the immunosuppressive effect of cyclophosphamide on antibody production in mice. (1989) (0)
Reply (1995) (0)
[In vitro biosynthesis of antibodies. I. Theoretical and methodological aspects]. (1982) (0)
Diminished t cell adhesion to extracellular matrix proteins in women with antiphospholipid antibodies (2000) (0)
Immune monitoring after renal transplantation. I. HLA-D expression on T cells from renal allograft recipients. (1991) (0)
4-hydro-peroxy-cyclophosphamide/4HPCy/: a strong inhibitor of immunoglobulin/Ig/synthesis of human lymphocytes (1982) (0)
[Clonal proliferation of T-lymphocytes in vitro]. (1978) (0)
Nowości Phage therapy as an alternative to infections with antibiotic-resistant bacteria (2006) (0)
Glucosteroid (GS)-dependent immunomodulation of immunoglobulin biosynthesis in vitro. I. GS stimulate spontaneous immunoglobulin synthesis. (1987) (0)
Cellular immunity in man assessed by indirect migration inhibition test using murine spleen leukocytes. (1973) (0)
Regulatory Effects of Heparin on Lymphocyte: Endothelial: Extracellular Matrix Interactions (1993) (0)
[Regulatory mechanisms of erythropoiesis in vitro]. (1980) (0)
[Perspectives of antisense therapy]. (1996) (0)
[Regulatory mechanisms of thrombocytopoiesis]. (1980) (0)
[Interaction of T lymphocytes with elastin and their significance in immunopathology]. (2002) (0)
Estimation of antigenicity of splenic microsomal fraction. (1969) (0)
B cell dysfunction in renal allograft recipients. (1987) (0)
IMMUNOLOGICAL RESPONSE AND CLINICAL RESULTS OF BACTERIOPHAGE THERAPY IN PATIENTS WITH CHRONIC BONE INFECTION. PRELIMINARY RESULTS (2005) (0)
Gammadeltaplus T cells in Wilson's disease (1995) (0)
Increased CD3-dependent lymphocyte proliferation in atopic dermatitis is modified by extracellular matrix proteins (1994) (0)
Bacteriophages and antibiotic interactions in clinical practice: what we have learned so far (2022) (0)
[Clonal proliferation of B lymphocytes]. (1980) (0)
[Immunologic deficits caused by abnormal phagocyte function]. (1974) (0)
TIME-DEPENDENT INHIBITION OF TR CELLS GENERATION IN MLR BY IMMUNOSUPPRESSIVE DRUGS. (2004) (0)
A purified bacteriophage, its preparation and use (2008) (0)
[Immunologic disorders in uremia]. (1974) (0)
T-cell interactions with components of vascular wall in patients with advanced atherosclerosis (1997) (0)
[Myelopietic regulatory mechanisms]. (1979) (0)
[Advances of clinical immunology. Carcinoembryonic antigen (CEA)]. (1973) (0)
[Changes in class II (HLA-D) antigen expression on T-lymphocytes in the recipients of allogeneic kidney transplants]. (1988) (0)
[The role of cell adhesion molecules in the pathogenesis of coronary artery disease]. (1996) (0)
Etanercept immunotherapy in women with a history of recurrent miscarriage (2010) (0)
[Transplantation of fetal liver cells]. (1977) (0)
ACTIVATION AND APOPTOSIS OF T AND B CELLS AFTER RENAL TRANSPLANTATION (2004) (0)
[Adhesion of human T lymphocytes and granulocytes to endothelial cells stimulated by cell-surface antigens of Bacteroides thetaiotaomicron]. (2000) (0)
[Cell membrane characteristics of B-lymphocytes in chronic lymphocytic leukemia. II. Expression of B-cell markers]. (1991) (0)
[Monoclonal antibodies]. (1981) (0)
P.131 Bacteriophage therapy in MRSA Staphyloccocal aureus empyema of anterior cranial fossa (2006) (0)
Increased myeloid colony growth in vitro of precultured progenitor cells. (1983) (0)
2-Chlorodeoxyadenosine: lack of synergism with cyclosporine A and tacrolimus (FK 506). (1995) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Andrzej Górski?

Andrzej Górski is affiliated with the following schools: